[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100351255":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":21,"locations":31,"responsibleParty":81,"collaborators":10,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":10,"eligibilityCriteria":91,"healthyVolunteers":87,"sex":92,"minAge":93,"maxAge":94,"enrollmentInfo":95,"targetDuration":10,"studyType":98,"phases":10,"briefSummary":99,"conditions":100,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":107,"lastUpdatePostDateStruct":108,"startDateStruct":111,"completionDateStruct":113,"leadSponsor":115,"locationsCount":116},{"fullName":5,"class":6},"Copenhagen University Hospital, Hvidovre","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Diagnostic imaging",null,"The progression of fibrosis will be assessed based on diagnostic imaging of thre subgroups including\n\nPatients with chronic pancreatitis (CP; N=50) of any aetiology, except gallstones, based on MANNHEIM.\n\nPatients with their first attack of acute pancreatitis (AP; N=50) of any aetiology except gallstones using the revised Atlanta criteria for AP.\n\nPatients with recurrent AP (RAP; N=50) except gallstones, defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.",[13],"Diagnostic Test: Diagnostic imaging",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"DIAGNOSTIC_TEST","MRI assessments including magnetic resonance cholangiopancreatography (MRCP) and diffusion weighted imaging (DWI) combined with gold standard EUS",[9],[20],"MRI and EUS",[22,27],{"name":23,"role":24,"phone":25,"phoneExt":10,"email":26},"Srdan Novovic, PhD","CONTACT","38623862","srdan.novovic@regionh.dk",{"name":28,"role":24,"phone":29,"phoneExt":10,"email":30},"Lise L Gluud, MSc","+45 38621964","lise.lotte.gluud.01@regionh.dk",[32,53,67],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Gastrounit, Copenhagen University Hospital Hvidovre","RECRUITING","Hvidovre","Capital Region Denmark","2650","Denmark","DK",{"type":41,"coordinates":42},"Point",[43,44],12.47708,55.64297,{"lat":44,"lon":43},[47,50],{"name":48,"role":24,"phone":49,"phoneExt":10,"email":30},"Lise L Gluud, MD","+4538621964",{"name":51,"role":24,"phone":52,"phoneExt":10,"email":26},"Srdan Novovic, MD","+38623862",{"facility":54,"status":34,"city":55,"state":10,"zip":56,"country":38,"countryCode":39,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Department of Gastroenterology & Hepatology, Aalborg University Hospital","Aalborg","9000",{"type":41,"coordinates":58},[59,60],9.9187,57.048,{"lat":60,"lon":59},[63],{"name":64,"role":24,"phone":65,"phoneExt":10,"email":66},"Soeren Schou Olesen, PhD","+45 97 66 00 00","soso@dcm.aau.dk",{"facility":68,"status":34,"city":69,"state":10,"zip":70,"country":38,"countryCode":39,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Abdominal Centre, Bispebjerg University Hospital","Copenhagen","2200",{"type":41,"coordinates":72},[73,74],12.56553,55.67594,{"lat":74,"lon":73},[77],{"name":78,"role":24,"phone":79,"phoneExt":10,"email":80},"Lars Nannestad Joergensen, PhD","+45 21 32 02 41","lars.nannestad.joergensen@regionh.dk",{"type":82,"investigatorFullName":83,"investigatorTitle":84,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Lise Gluud","Associate Professor","100351255","fibro-inflammatory-progression-from-acute-to-chronic-pancreatitis-100351255",false,"NCT03853447","Fibro-inflammatory Progression From Acute to Chronic Pancreatitis","Characterization of Fibro-inflammation During Progression From Acute to Chronic Pancreatitis","Inclusion Criteria:\n\n* Patients with CP (N=50) of any aetiology except gallstone induced CP: CP will be diagnosed based on MANNHEIM criteria .\n* Cohort 2: Patients with their first attack of AP of any aetiology except gallstone induced AP (N=50). The revised Atlanta criteria for acute pancreatitis will be used as diagnostic criteria.\n* Cohort 3: Patients with RAP (N=50) except gallstone induced RAP. RAP is defined as two or more cases of AP as diagnosed by the revised Atlanta Criteria.\n\nExclusion Criteria:","ALL","18 Years","70 Years",{"count":96,"type":97},150,"ESTIMATED","OBSERVATIONAL","Observational prospective study evaluating the developement of chronic pancreatitis based on imaging modalities as well as biochemical markers of inflammation, fibrosis and oxidative stress.",[101,102,103,104,105,106],"Pancreatitis","Acute Pancreatitis","Recurrent Pancreatitis","Chronic Pancreatitis","Inflammation","Fibrosis","2020-04-07",{"date":109,"type":110},"2020-04-08","ACTUAL",{"date":112,"type":110},"2019-02-14",{"date":114,"type":97},"2041-01-01",{"name":5,"class":6},3]